Linezolid-induced thrombocytopenia increases mortality risk in intensive care unit patients, a 10 year retrospective study

Abstract

Critically ill patients with any malignancy or an elevated baseline creatinine level who were treated with linezolid in the ICU were more likely to develop thrombocytopenia. More importantly, mortality increased with patients who developed linezolid-induced thrombocytopenia compared to those did not.